Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Melissa Shipley"'
Publikováno v:
Proceedings of the Institution of Civil Engineers - Management, Procurement and Law. 172:218-223
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9e77a1eead848ae8d0ce7a0f88f04ae
https://doi.org/10.1680/jmapl.2019.172.5.218
https://doi.org/10.1680/jmapl.2019.172.5.218
Autor:
Paul E. Kinahan, David Shelley, Kristin J. Lastwika, Sudhakar Pipavath, Melissa Shipley, Yuzheng Zhang, Wei Wu, Xiaodong Zhu, Paul D. Lampe, Jon Ladd, Julia Kargl, A. McGarry Houghton, Edward Lo, Timothy W. Randolph
Publikováno v:
Am J Respir Crit Care Med
Rationale: Screening for non–small cell lung cancer is associated with earlier diagnosis and reduced mortality but also increased harm caused by invasive follow-up of benign pulmonary nodules. Lung tumorigenesis activates the immune system, compone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f28f0714b224f5e0206948f86058521
https://doi.org/10.1164/rccm.201804-0628oc
https://doi.org/10.1164/rccm.201804-0628oc
Autor:
Paul Darling QC, Melissa Shipley
This chapter explores assignment, which denotes the transfer of contractual rights from one party to another. It explains how there can be no assignment of the burden of a contract without the consent of the other contracting party. This chapter also
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::523f94b7ada78a9d63988d5c2d88d5ea
https://doi.org/10.1093/oso/9780198832805.003.0004
https://doi.org/10.1093/oso/9780198832805.003.0004
Autor:
A. McGarry Houghton, Melissa Shipley, Jill McKay-Fleisch, Afshin Mashadi-Hossein, Gavin Meredith, Julia Kargl, John A. Zebala, Robert H. Pierce, Grace H. Y. Yang, Jeffrey C. Thompson, Dean Y. Maeda, Huajia Zhang, Steven M. Albelda, Xiaodong Zhu, Christina S. Baik, Hamid Bolouri, Mary W. Redman, Travis J. Friesen
Publikováno v:
JCI insight. 4(24)
Immune checkpoint inhibitor (ICI) treatment has recently become a first-line therapy for many non–small cell lung cancer (NSCLC) patients. Unfortunately, most NSCLC patients are refractory to ICI monotherapy, and initial attempts to address this is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fc5f3c9e149505e2fd6df8d36cabb31
https://pubmed.ncbi.nlm.nih.gov/31852845
https://pubmed.ncbi.nlm.nih.gov/31852845
Autor:
Regine M. Schoenherr, Amanda G. Paulovich, Jeffrey R. Whiteaker, Melissa Lerch, Melissa Shipley, Kimberly H. Allison, Andrew N. Hoofnagle, Geoffrey S. Baird, Jacob J. Kennedy, Ping Yan
Publikováno v:
Journal of Proteome Research. 15:2717-2728
Despite a clinical, economic, and regulatory imperative to develop companion diagnostics, precious few new biomarkers have been successfully translated into clinical use, due in part to inadequate protein assay technologies to support large-scale tes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcc71523047dc4e35499b12c770b04f5
https://doi.org/10.1021/acs.jproteome.6b00245
https://doi.org/10.1021/acs.jproteome.6b00245
Publikováno v:
New Zealand Management. Dec2005, Vol. 52 Issue 11, p12-12. 1p.
Publikováno v:
Management, Procurement & Law: Proceedings of the Institution of Civil Engineers; Oct2019, Vol. 172 Issue 5, p218-223, 6p
Autor:
Klein, Sarah A.
Publikováno v:
Crain's Chicago Business. 8/6/2007, Vol. 30 Issue 32, p30-31. 2p. 3 Color Photographs, 1 Map.